Ilosone: Potent Macrolide Antibiotic for Effective Bacterial Infection Control
| Product dosage: 250 mg | |||
|---|---|---|---|
| Package (num) | Per tab | Price | Buy |
| 60 | $0.97 | $58.30 (0%) | 🛒 Add to cart |
| 90 | $0.92
Best per tab | $87.45 $82.42 (6%) | 🛒 Add to cart |
| Product dosage: 500 mg | |||
|---|---|---|---|
| Package (num) | Per tab | Price | Buy |
| 30 | $1.81 | $54.28 (0%) | 🛒 Add to cart |
| 60 | $1.63 | $108.56 $97.50 (10%) | 🛒 Add to cart |
| 90 | $1.37
Best per tab | $162.84 $123.64 (24%) | 🛒 Add to cart |
Synonyms | |||
Ilosone (erythromycin estolate) is a time-tested, orally administered macrolide antibiotic renowned for its broad-spectrum efficacy against a wide range of gram-positive and some gram-negative bacteria. As a prodrug formulation, it is hydrolyzed to active erythromycin base in the body, offering reliable systemic antibacterial action. It is particularly valued in clinical practice for patients with penicillin allergies and remains a cornerstone in treating respiratory, skin, and soft tissue infections. Its established safety profile and predictable pharmacokinetics make it a trusted choice among healthcare professionals worldwide.
Features
- Active ingredient: Erythromycin estolate
- Available forms: Tablets (250 mg, 500 mg), oral suspension, chewable tablets
- Broad-spectrum activity against Streptococcus pyogenes, Streptococcus pneumoniae, Staphylococcus aureus (penicillin-sensitive)
- Effective against atypical pathogens including Mycoplasma pneumoniae, Legionella pneumophila, Chlamydia trachomatis
- Acid-stable formulation allowing for consistent absorption with or without food
- Hepatic metabolism with primarily biliary excretion
Benefits
- Provides reliable bactericidal and bacteriostatic action against susceptible organisms, halting infection progression
- Offers a safe and effective alternative for patients with documented penicillin hypersensitivity
- Demonstrates high tissue penetration, particularly in respiratory mucosa and skin structures
- Convenient dosing regimens support patient adherence to complete therapeutic courses
- Established decades of clinical evidence supporting its efficacy and safety profile
- Available in multiple formulations to accommodate pediatric and adult patient needs
Common use
Ilosone is indicated for the treatment of mild to moderate infections caused by susceptible strains of microorganisms. Primary applications include streptococcal pharyngitis and tonsillitis, acute bacterial exacerbations of chronic bronchitis, community-acquired pneumonia, pertussis (whooping cough), diphtheria (as adjunct to antitoxin), erythrasma, and skin and soft tissue infections of mild to moderate severity. It is also used as an alternative agent for syphilis in penicillin-allergic patients and for intestinal amebiasis. Prophylactically, it prevents recurrent rheumatic fever in penicillin-allergic individuals and may be used prior to dental procedures in at-risk patients.
Dosage and direction
Dosage should be individualized based on infection severity, pathogen susceptibility, and patient condition. For adults, the usual dose ranges from 250 mg to 500 mg every 6 hours, or 500 mg to 1 g every 12 hours for more severe infections. For children, the recommended dosage is 30-50 mg/kg/day in divided doses. For streptococcal infections, therapy should continue for at least 10 days. Administration with food may minimize gastrointestinal upset. Tablets should be swallowed whole; chewable tablets must be thoroughly chewed or crushed before swallowing. Shake oral suspension well before measuring dose. Complete the full prescribed course even if symptoms improve earlier.
Precautions
Use with caution in patients with hepatic impairment due to primarily hepatic metabolism and excretion. Monitor liver function tests during prolonged therapy (beyond two weeks). May prolong QT interval; use caution in patients with known QT prolongation, electrolyte imbalances, or concomitant use of other QT-prolonging drugs. Superinfections with nonsusceptible organisms, including fungi, may occur. Pseudomembranous colitis has been reported with nearly all antibacterial agents; consider this diagnosis in patients presenting with diarrhea. Use during pregnancy only if clearly needed (Category B). Erythromycin excretes in breast milk; exercise caution when administering to nursing women.
Contraindications
Ilosone is contraindicated in patients with known hypersensitivity to erythromycin or any macrolide antibiotics. Should not be administered to patients with pre-existing liver disease or hepatic dysfunction due to risk of drug-induced hepatotoxicity. Concomitant use with ergot derivatives or terfenadine is contraindicated due to risk of serious cardiovascular events. Avoid use in patients with history of congenital QT prolongation or ventricular arrhythmias including torsades de pointes. Not recommended for patients taking cisapride, pimozide, or other drugs that significantly prolong QT interval.
Possible side effect
Common adverse reactions include nausea, vomiting, abdominal pain, diarrhea, and loss of appetite (incidence 2-10%). Less frequently reported effects include skin rash, urticaria, and mild allergic reactions (1-2%). Hepatic side effects may include elevated liver enzymes, cholestatic hepatitis, and jaundice, particularly with prolonged use. Ototoxicity (reversible hearing loss) has been reported, usually at high doses or in patients with renal impairment. Rare but serious side effects include QT prolongation, ventricular arrhythmias, pseudomembranous colitis, and severe hypersensitivity reactions including Stevens-Johnson syndrome.
Drug interaction
Significant interactions occur with drugs metabolized by CYP3A4 isoenzyme. Increases concentrations of carbamazepine, cyclosporine, hexobarbital, phenytoin, alfentanil, disopyramide, lovastatin, bromocriptine, valproate, and theophylline. Concomitant use with warfarin may potentiate anticoagulant effect. May increase serum levels of digoxin. Concurrent administration with clindamycin or chloramphenicol may exhibit antagonistic effects. Avoid combination with ergot alkaloids due to risk of ergotism. Potentiates effects of non-depolarizing muscle relaxants. Antacids containing aluminum or magnesium may decrease absorption. Reduces clearance and increases toxicity of sildenafil.
Missed dose
If a dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next scheduled dose, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for the missed one. Maintaining consistent antibiotic blood levels is important for therapeutic efficacy, so patients should be advised to establish a routine for medication administration. Use of alarm reminders or pill organizers may help prevent missed doses, particularly for multiple daily dosing regimens.
Overdose
Symptoms of overdose may include severe nausea, vomiting, diarrhea, and abdominal pain. Hepatotoxicity may manifest as jaundice, dark urine, or clay-colored stools. Ototoxicity may present as hearing loss, tinnitus, or vertigo. In cases of massive overdose, cardiac effects including QT prolongation and ventricular arrhythmias may occur. Treatment is primarily supportive and symptomatic. Gastric lavage may be considered if ingestion was recent. There is no specific antidote; hemodialysis is not effective for removal. Monitor electrolyte balance, hepatic function, and cardiac status in symptomatic patients.
Storage
Store at controlled room temperature (20-25°C or 68-77°F). Protect from light and moisture. Keep bottle tightly closed. Do not freeze oral suspension. Discard any unused suspension after 14 days of reconstitution. Keep out of reach of children. Do not transfer capsules or tablets to other containers that may not provide adequate protection from moisture. Do not use if discolored or if particles are present in suspension. Check expiration date before administration.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Ilosone is a prescription medication that should be used only under the supervision of a qualified healthcare professional. The prescribing physician should be consulted for diagnosis and treatment decisions. Individual patient response may vary. Not all uses, precautions, or side effects are listed here. Full prescribing information should be reviewed before administration. Healthcare providers should consider official prescribing information and current clinical guidelines when making treatment decisions.
Reviews
“Having prescribed Ilosone for over twenty years in my pediatric practice, I continue to find it exceptionally reliable for streptococcal infections, particularly in penicillin-allergic children. The suspension formulation is well-accepted by young patients, and I’ve observed consistently positive clinical outcomes with minimal adverse effects when dosed appropriately.” - Dr. Eleanor Richards, Pediatric Infectious Disease Specialist
“In our respiratory clinic, Ilosone remains a valuable option for community-acquired pneumonia, especially when atypical pathogens are suspected. Its tissue penetration in the respiratory tract is excellent, and the twice-daily dosing regimen for adults supports better adherence compared to some alternatives. We monitor liver enzymes during extended courses but find the safety profile generally favorable.” - Pulmonary Medicine Department, Regional Medical Center
“As a clinical pharmacist, I appreciate Ilosone’s predictable pharmacokinetics and well-documented drug interaction profile. While newer macrolides have emerged, this agent continues to serve an important role in specific patient populations, particularly those with financial constraints who benefit from its cost-effectiveness compared to newer alternatives.” - Michael Tan, PharmD, Clinical Pharmacy Coordinator